Header Logo

Connection

ANDRAS HECZEY to Immunotherapy

Back to Details
This is a "connection" page, showing publications ANDRAS HECZEY has written about Immunotherapy.
ANDRAS HECZEY
Connection Strength
0.485
Immunotherapy
  1. Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy. Blood. 2014 Oct 30; 124(18):2824-33.
    View in: PubMed
    Score: 0.191
  2. Advances in chimeric antigen receptor immunotherapy for neuroblastoma. Discov Med. 2013 Dec; 16(90):287-94.
    View in: PubMed
    Score: 0.183
  3. Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy. J Immunol Res. 2017; 2017:5604891.
    View in: PubMed
    Score: 0.057
  4. Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity. Hum Gene Ther. 2017 05; 28(5):437-448.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.